Results for Tau phosphorylated at threonine 181 (p-tau181)

Publications & Outputs

1. Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer’s disease and Down syndrome

   Tatebe, H., Kasai, T., Ohmichi, T., Kishi, Y., Kakeya, T., Waragai, M., Kondo, M., Allsop, D. & Tokuda, T., 4/09/2017, In: Molecular Neurodegeneration. 12, 63, 11 p., 63.

   Research output: Contribution to Journal/Magazine › Journal article › peer-review